首页> 外文期刊>Journal of Biophotonics >Photonic crystal enhanced fluorescence for early breast cancer biomarker detection
【24h】

Photonic crystal enhanced fluorescence for early breast cancer biomarker detection

机译:光子晶体增强的荧光用于早期乳腺癌生物标志物检测

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Photonic crystal surfaces offer a compelling platform for improving the sensitivity of surface-based fluorescent assays used in disease diagnostics. Through the complementary processes of photonic crystal enhanced excitation and enhanced extraction, a periodic dielectric-based nanostructured surface can simultaneously increase the electric field intensity experienced by surface-bound fluorophores and increase the collection efficiency of emitted fluorescent photons. Through the ability to inexpensively fabricate photonic crystal surfaces over substantial surface areas, they are amenable to single-use applications in biological sensing, such as disease biomarker detection in serum. In this review, we will describe the motivation for implementing high-sensitivity, multiplexed biomarker detection in the context of breast cancer diagnosis. We will summarize recent efforts to improve the detection limits of such assays though the use of photonic crystal surfaces. Reduction of detection limits is driven by low autofluorescent substrates for photonic crystal fabrication, and detection instruments that take advantage of their unique features. ((c) 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim)
机译:光子晶体表面提供了一个引人注目的平台,可提高疾病诊断中基于表面的荧光测定的灵敏度。通过光子晶体增强激发和增强提取的互补过程,周期性的基于电介质的纳米结构表面可以同时增加表面结合的荧光团所经历的电场强度,并提高发射的荧光光子的收集效率。通过能够廉价地在较大表面积上制造光子晶体表面的能力,它们适合于生物传感(例如血清中的疾病生物标志物检测)的一次性应用。在这篇综述中,我们将描述在乳腺癌诊断中实施高灵敏度,多重生物标志物检测的动机。我们将总结最近通过使用光子晶体表面来改善此类检测的检测限的努力。用于光子晶体制造的低自发荧光基板和利用其独特功能的检测仪器,可降低检测限。 ((c)2012 WILEY-VCH Verlag GmbH&Co.KGaA,Weinheim)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号